• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索具有药物重要性的铅化合物的海洋蓝细菌。

Exploring marine cyanobacteria for lead compounds of pharmaceutical importance.

作者信息

Uzair Bushra, Tabassum Sobia, Rasheed Madiha, Rehman Saima Firdous

机构信息

Department of Bioinformatics and Biotechnology, International Islamic University Islamabad, Sector H-10, 44000 Islamabad, Pakistan.

出版信息

ScientificWorldJournal. 2012;2012:179782. doi: 10.1100/2012/179782. Epub 2012 Apr 1.

DOI:10.1100/2012/179782
PMID:22545008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3324129/
Abstract

The Ocean, which is called the "mother of origin of life," is also the source of structurally unique natural products that are mainly accumulated in living organisms. Cyanobacteria are photosynthetic prokaryotes used as food by humans. They are excellent source of vitamins and proteins vital for life. Several of these compounds show pharmacological activities and are helpful for the invention and discovery of bioactive compounds, primarily for deadly diseases like cancer, acquired immunodeficiency syndrome (AIDS), arthritis, and so forth, while other compounds have been developed as analgesics or to treat inflammation, and so forth. They produce a large variety of bioactive compounds, including substances with anticancer and antiviral activity, UV protectants, specific inhibitors of enzymes, and potent hepatotoxins and neurotoxins. Many cyanobacteria produce compounds with potent biological activities. This paper aims to showcase the structural diversity of marine cyanobacterial secondary metabolites with a comprehensive coverage of alkaloids and other applications of cyanobacteria.

摘要

被称为“生命起源之母”的海洋,也是结构独特的天然产物的来源,这些天然产物主要积累在生物体内。蓝细菌是作为人类食物的光合原核生物。它们是对生命至关重要的维生素和蛋白质的优质来源。其中一些化合物具有药理活性,有助于生物活性化合物的发明和发现,主要针对癌症、获得性免疫缺陷综合征(艾滋病)、关节炎等致命疾病,而其他化合物已被开发用作镇痛药或治疗炎症等。它们产生各种各样的生物活性化合物,包括具有抗癌和抗病毒活性的物质、紫外线保护剂、酶的特异性抑制剂以及强效肝毒素和神经毒素。许多蓝细菌产生具有强大生物活性的化合物。本文旨在展示海洋蓝细菌次生代谢产物的结构多样性,并全面涵盖生物碱以及蓝细菌的其他应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/e9514d6e4fee/TSWJ2012-179782.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/66e9a1266509/TSWJ2012-179782.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/ede5a34328d2/TSWJ2012-179782.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/4d99486f405e/TSWJ2012-179782.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/6a29ddc3b3cf/TSWJ2012-179782.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/89741efa42b7/TSWJ2012-179782.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/2e292570b168/TSWJ2012-179782.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/b71d77fb98d7/TSWJ2012-179782.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/4fa48dd5a984/TSWJ2012-179782.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/9129ba7a6379/TSWJ2012-179782.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/7e093e7aa525/TSWJ2012-179782.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/e9514d6e4fee/TSWJ2012-179782.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/66e9a1266509/TSWJ2012-179782.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/ede5a34328d2/TSWJ2012-179782.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/4d99486f405e/TSWJ2012-179782.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/6a29ddc3b3cf/TSWJ2012-179782.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/89741efa42b7/TSWJ2012-179782.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/2e292570b168/TSWJ2012-179782.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/b71d77fb98d7/TSWJ2012-179782.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/4fa48dd5a984/TSWJ2012-179782.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/9129ba7a6379/TSWJ2012-179782.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/7e093e7aa525/TSWJ2012-179782.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc1d/3324129/e9514d6e4fee/TSWJ2012-179782.011.jpg

相似文献

1
Exploring marine cyanobacteria for lead compounds of pharmaceutical importance.探索具有药物重要性的铅化合物的海洋蓝细菌。
ScientificWorldJournal. 2012;2012:179782. doi: 10.1100/2012/179782. Epub 2012 Apr 1.
2
Bioactive natural products from marine cyanobacteria for drug discovery.用于药物研发的海洋蓝藻生物活性天然产物
Phytochemistry. 2007 Apr;68(7):954-79. doi: 10.1016/j.phytochem.2007.01.012. Epub 2007 Mar 2.
3
Marine Cyanobacteria: A Source of Lead Compounds and their Clinically-Relevant Molecular Targets.海洋蓝细菌:铅化合物的来源及其具有临床相关性的分子靶标。
Molecules. 2020 May 8;25(9):2197. doi: 10.3390/molecules25092197.
4
Pharmaceutical agents from filamentous marine cyanobacteria.海洋丝状蓝藻来源的药物制剂。
Drug Discov Today. 2013 Sep;18(17-18):863-71. doi: 10.1016/j.drudis.2013.05.010. Epub 2013 May 25.
5
Immense essence of excellence: marine microbial bioactive compounds.卓越的精髓:海洋微生物生物活性化合物。
Mar Drugs. 2010 Oct 15;8(10):2673-701. doi: 10.3390/md8102673.
6
Marine Cyanobacteria: A Rich Source of Structurally Unique Anti-Infectives for Drug Development.海洋蓝细菌:用于药物开发的结构独特抗感染药物的丰富来源。
Molecules. 2024 Nov 10;29(22):5307. doi: 10.3390/molecules29225307.
7
Biologically active secondary metabolites from marine cyanobacteria.海洋蓝细菌中的生物活性次生代谢产物。
Curr Opin Biotechnol. 2010 Dec;21(6):787-93. doi: 10.1016/j.copbio.2010.09.019. Epub 2010 Oct 26.
8
A review of pharmacological and toxicological potentials of marine cyanobacterial metabolites.海洋蓝藻代谢产物的药理和毒理学潜力综述。
J Appl Toxicol. 2012 Mar;32(3):153-85. doi: 10.1002/jat.1717. Epub 2011 Sep 9.
9
Biotechnological Applications of Bioactive Peptides From Marine Sources.海洋源生物活性肽的生物技术应用。
Adv Microb Physiol. 2018;73:171-220. doi: 10.1016/bs.ampbs.2018.05.002. Epub 2018 Jun 20.
10
Marine Cyanobacteria and Microalgae Metabolites-A Rich Source of Potential Anticancer Drugs.海洋蓝细菌和微藻代谢产物——潜在抗癌药物的丰富来源。
Mar Drugs. 2020 Sep 19;18(9):476. doi: 10.3390/md18090476.

引用本文的文献

1
The Chemistry of Phytoplankton.浮游植物的化学
Chem Rev. 2024 Dec 11;124(23):13099-13177. doi: 10.1021/acs.chemrev.4c00177. Epub 2024 Nov 21.
2
Biomedical engineering utilizing living photosynthetic cyanobacteria and microalgae: Current status and future prospects.利用光合蓝细菌和微藻的生物医学工程:现状与未来展望。
Mater Today Bio. 2024 Jul 14;27:101154. doi: 10.1016/j.mtbio.2024.101154. eCollection 2024 Aug.
3
Network pharmacology‒based analysis of marine cyanobacteria derived bioactive compounds for application to Alzheimer's disease.

本文引用的文献

1
Lyngbyastatins 8-10, elastase inhibitors with cyclic depsipeptide scaffolds isolated from the marine cyanobacterium Lyngbya semiplena.林可霉素类 8-10,弹性蛋白酶抑制剂,具有来源于海洋蓝藻 Lyngbya semiplena 的环状 depsipeptide 支架。
Mar Drugs. 2009 Nov 3;7(4):528-38. doi: 10.3390/md7040528.
2
Molassamide, a depsipeptide serine protease inhibitor from the marine cyanobacterium Dichothrix utahensis.从海洋蓝藻 Dichothrix utahensis 中分离得到的一种肽酰基丝氨酸蛋白酶抑制剂 Molassamide。
J Nat Prod. 2010 Mar 26;73(3):459-62. doi: 10.1021/np900603f.
3
Carriebowmide, a new cyclodepsipeptide from the marine cyanobacterium Lyngbya polychroa.
基于网络药理学的海洋蓝藻衍生生物活性化合物在阿尔茨海默病中的应用分析
Front Pharmacol. 2023 Oct 19;14:1249632. doi: 10.3389/fphar.2023.1249632. eCollection 2023.
4
Review of Marine Cyanobacteria and the Aspects Related to Their Roles: Chemical, Biological Properties, Nitrogen Fixation and Climate Change.海洋蓝细菌综述及其相关角色:化学、生物学特性、固氮作用和气候变化。
Mar Drugs. 2023 Aug 3;21(8):439. doi: 10.3390/md21080439.
5
Absolute Stereochemistry Determination of Bioactive Marine-Derived Cyclopeptides by Liquid Chromatography Methods: An Update Review (2018-2022).运用液相色谱法测定具有生物活性的海洋衍生环肽的绝对立体化学:最新综述(2018-2022)。
Molecules. 2023 Jan 7;28(2):615. doi: 10.3390/molecules28020615.
6
Marine Cyclic Peptides: Antimicrobial Activity and Synthetic Strategies.海洋环肽:抗菌活性与合成策略。
Mar Drugs. 2022 Jun 15;20(6):397. doi: 10.3390/md20060397.
7
Phytoplankton Toxins and Their Potential Therapeutic Applications: A Journey toward the Quest for Potent Pharmaceuticals.浮游植物毒素及其潜在的治疗应用:探索强效药物的征程。
Mar Drugs. 2022 Apr 18;20(4):271. doi: 10.3390/md20040271.
8
Inhibition of Filamentous Thermosensitive Mutant-Z Protein in by Cyanobacterial Bioactive Compounds.蓝藻生物活性化合物对丝状热敏感突变 Z 蛋白的抑制作用。
Molecules. 2022 Mar 15;27(6):1907. doi: 10.3390/molecules27061907.
9
Bioactive Potential of Two Marine Picocyanobacteria Belonging to and Genera.属于聚球藻属和原绿球藻属的两种海洋蓝细菌的生物活性潜力。
Microorganisms. 2021 Sep 28;9(10):2048. doi: 10.3390/microorganisms9102048.
10
Cyanobacteria-From the Oceans to the Potential Biotechnological and Biomedical Applications.蓝藻——从海洋到潜在的生物技术和生物医学应用。
Mar Drugs. 2021 Apr 24;19(5):241. doi: 10.3390/md19050241.
卡里鲍米德,一种从海洋蓝藻多色鞘丝藻中提取的新型环缩肽。
J Nat Prod. 2008 Dec;71(12):2060-3. doi: 10.1021/np800453t.
4
Unraveling the genomic mosaic of a ubiquitous genus of marine cyanobacteria.解析一种常见海洋蓝细菌属的基因组镶嵌现象。
Genome Biol. 2008;9(5):R90. doi: 10.1186/gb-2008-9-5-r90. Epub 2008 May 28.
5
Lyngbyastatins 5-7, potent elastase inhibitors from Floridian marine cyanobacteria, Lyngbya spp.林格比他汀5 - 7,源自佛罗里达海洋蓝藻林格比属(Lyngbya spp.)的强效弹性蛋白酶抑制剂。
J Nat Prod. 2007 Oct;70(10):1593-600. doi: 10.1021/np0702436. Epub 2007 Oct 3.
6
A novel method of single step hydrophobic interaction chromatography for the purification of phycocyanin from Phormidium fragile and its characterization for antioxidant property.一种从脆弱席藻中纯化藻蓝蛋白的单步疏水相互作用色谱新方法及其抗氧化性能表征。
Bioresour Technol. 2008 Jan;99(1):188-94. doi: 10.1016/j.biortech.2006.11.010. Epub 2007 Jan 17.
7
Trungapeptins A-C, cyclodepsipeptides from the marine cyanobacterium Lyngbya majuscula.来自海洋蓝藻巨大鞘丝藻的环缩肽类化合物中平肽A-C。
J Nat Prod. 2006 Nov;69(11):1539-42. doi: 10.1021/np050485a.
8
Chemical deterrence of a cyanobacterial metabolite against generalized and specialized grazers.一种蓝藻代谢物对广义和狭义食草动物的化学威慑作用。
J Chem Ecol. 2007 Jan;33(1):213-7. doi: 10.1007/s10886-006-9212-y. Epub 2006 Oct 25.
9
Phase I and pharmacokinetic study of tasidotin hydrochloride (ILX651), a third-generation dolastatin-15 analogue, administered weekly for 3 weeks every 28 days in patients with advanced solid tumors.盐酸他西多汀(ILX651)的Ⅰ期和药代动力学研究,这是一种第三代多拉司他汀-15类似物,在晚期实体瘤患者中每28天给药一次,每周给药3周。
Clin Cancer Res. 2006 Sep 1;12(17):5207-15. doi: 10.1158/1078-0432.CCR-06-0179.
10
Largamides A-H, unusual cyclic peptides from the marine cyanobacterium Oscillatoria sp.拉加米德A - H,源自海洋蓝藻颤藻属的异常环肽
J Org Chem. 2006 Sep 1;71(18):6898-907. doi: 10.1021/jo061044e.